Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
End Stage Renal Failure on Dialysis: full-pipeline trial registry
1 of 4 indexed End Stage Renal Failure on Dialysis trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
End Stage Renal Failure on Dialysis: 4 US clinical trials tracked, 1 recruiting.
End Stage Renal Failure on Dialysis is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Mozarc Medical US, running 1 of these trials.
Enrollment posture brief
Registry condition end-stage-renal-failure-on-dialysis
OPEN 1 | RECR 25% | LATE 1 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
End Stage Renal Failure on Dialysis lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for End Stage Renal Failure on Dialysis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
End Stage Renal Failure on Dialysis is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
CAR-T Cell Therapy for Desensitization in Kidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06056102
ISCHEMIA-Chronic Kidney Disease Trial
NYU Langone Health
NCT01985360
Argyle Safety Fistula Cannula With Anti-reflux Valve Clinical Study
Mozarc Medical US
NCT05927532
Blood Volume Analysis and Renal Outcomes in Hemodialysis
VA New York Harbor Healthcare System
NCT02717533
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on End Stage Renal Failure on Dialysis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on End Stage Renal Failure on Dialysis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this End Stage Renal Failure on Dialysis page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 End Stage Renal Failure on Dialysis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Mozarc Medical US sponsors the most End Stage Renal Failure on Dialysis trials on record, review their full trial history before evaluating a specific study. See Mozarc Medical US's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This End Stage Renal Failure on Dialysis condition card totals 4 registered trials; most-linked intervention Percutaneous Coronary Intervention; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.